Restless legs syndrome: nonpharmacologic and pharmacologic treatments

Geriatrics. 2007 Oct;62(10):13-6.

Abstract

Treatment of restless legs syndrome (RLS) has as its goals alleviation of the primary symptoms of the disorder and establishment of normal sleep. Dopamine agonists are considered first-line treatment when daily treatment for primary RLS is indicated. Gabapentin and opioids may be of value for refractory cases. Initial treatment of secondary RLS should address the underlying cause.

Publication types

  • Review

MeSH terms

  • Amines / administration & dosage
  • Amines / therapeutic use
  • Anemia, Iron-Deficiency / complications
  • Anemia, Iron-Deficiency / drug therapy
  • Anticonvulsants / administration & dosage
  • Benzothiazoles / administration & dosage
  • Benzothiazoles / metabolism
  • Clonazepam / administration & dosage
  • Cyclohexanecarboxylic Acids / administration & dosage
  • Cyclohexanecarboxylic Acids / therapeutic use
  • Dopamine Agents / administration & dosage
  • Dopamine Agonists / administration & dosage
  • Dopamine Agonists / metabolism
  • Dopamine Agonists / therapeutic use*
  • Ferritins / blood
  • Gabapentin
  • Humans
  • Indoles / administration & dosage
  • Iron / administration & dosage
  • Levodopa / administration & dosage
  • Pramipexole
  • Restless Legs Syndrome / drug therapy*
  • Restless Legs Syndrome / etiology
  • Restless Legs Syndrome / therapy
  • Trace Elements / administration & dosage
  • gamma-Aminobutyric Acid / administration & dosage
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • Amines
  • Anticonvulsants
  • Benzothiazoles
  • Cyclohexanecarboxylic Acids
  • Dopamine Agents
  • Dopamine Agonists
  • Indoles
  • Trace Elements
  • ropinirole
  • Levodopa
  • gamma-Aminobutyric Acid
  • Clonazepam
  • Gabapentin
  • Pramipexole
  • Ferritins
  • Iron